436809-79-9

Upstream product

• 436809-78-8 [4-(4-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-5-yl]-(4-chloromethylphenyl)-methanone 
• 1711-02-0 4-iodobenzoic acid chloride 
• 213462-12-5 4-(4-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine 
• 308287-51-6 [4-(4-chloro-phenyl)-6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl]-(4-hydroxymethyl-phenyl)-methanone 
• 436809-77-7 [4-(4-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-5-yl]-(4-formylphenyl)-methanone 
• 436809-76-6 [4-(4-chlorophenyl)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-5-yl]-(4-iodiophenyl)methanone 

Downstream Products

• 436809-82-4 2-(2-tert-butoxycarbonylamino-4-{4-[4-(4-chlorophenyl)-6,7-dihydro-4H-thieno[3,2-c]pyridine-5-carbonyl]benzyl-carbamoyl}butyrylamino)propionic acid tert-butyl ester 
• 436809-80-2 (4-aminomethyl-phenyl)-[4-(4-chloro-phenyl)-6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl]-methanone 

Relevant academic research and scientific papers

Application of enzymatically stable dipeptides for enhancement of intestinal permeability. Synthesis and in vitro evaluation of dipeptide-coupled compounds

Transport across the intestinal barrier of compounds with low permeability may be facilitated by targeting the human oligopeptide transporter, hPepT1. A flexible synthetic pathway for attaching compounds to dipeptides through ester or amide bonds was deve